Cytomegalovirus infection in bone marrow-transplant patients

C. Cicogna, B. Polsky

Research output: Contribution to journalShort surveypeer-review

Abstract

Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality among patients receiving allogeneic bone marrow transplantation. Pneumonia is the most serious manifestation, with an incidence of 15% to 30%. Although the use of ganciclovir with intravenous immunoglobulin has improved survival, CMV pneumonitis is often fatal, underscoring the need for effective prophylaxis.

Original languageEnglish
Pages (from-to)258+261-262
JournalInfections in Medicine
Volume11
Issue number4
StatePublished - 1994
Externally publishedYes

Keywords

  • cancer
  • cytomegalovirus (CMV)
  • ganciclovir
  • immunoglobulin
  • pneumonitis

Fingerprint

Dive into the research topics of 'Cytomegalovirus infection in bone marrow-transplant patients'. Together they form a unique fingerprint.

Cite this